This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Crown Bioscience, Inc. (Taicang). Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: Jinying Ning: Innovator in Cancer Research
Introduction
Jinying Ning is a prominent inventor based in Jiangsu, China. She has made significant contributions to the field of cancer research, particularly in the development of methods for predicting the responsiveness of cancer cells to specific treatments. Her innovative work has the potential to enhance personalized medicine approaches in oncology.
Latest Patents
Jinying Ning holds a patent titled "Methods for determining responsiveness to MEK/ERK inhibitors." This patent describes a method for predicting the responsiveness of a cancer cell to an MEK inhibitor. The method involves detecting the presence of mutations in genes such as ADAM12, COL14A1, TNN, and TP53. By analyzing these mutations, the method can indicate decreased responsiveness of cancer cells to ERK inhibitors, thereby guiding treatment decisions.
Career Highlights
Jinying Ning is currently employed at Crown Bioscience, Inc., located in Taicang. Her role at the company allows her to collaborate with other experts in the field and contribute to groundbreaking research in cancer therapies.
Collaborations
Some of her notable coworkers include Sheng Guo and Wubin Qian. Their collective expertise fosters a collaborative environment that enhances the research output at Crown Bioscience.
Conclusion
Jinying Ning's innovative work in cancer research exemplifies the impact of targeted therapies in improving patient outcomes. Her contributions through patents and collaborations continue to advance the field of oncology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile